リファイン すべてリセット
距離:
ソート
雇用主/採用担当者
掲載日
所在地
職種
雇用主/採用担当者
すべてのフィルタ

Cancerの求人-南砺 - 9 Job Positions Available

上位都市:
9 / 1 - 9 求人
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  27日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  23日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  23日前
Bristol Myers Squibb 求人

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department.

Bristol Myers Squibb  19日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  19日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  19日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  16日前
Tenet Healthcare 求人

Overview Metrowest Medical Center - Consolidated Hospital is committed to providing exceptional patient care in a supportive and collaborative environment. As a member of our team, you will have the opportunity to work with advanced technology

Tenet Healthcare  12日前
Tenet Healthcare 求人

Overview Join our dedicated healthcare team where compassion meets innovation! As a Registered Nurse with us, youll have the opportunity to make a meaningful impact in patients lives while enjoying a supportive work environment that fosters

Tenet Healthcare  9日前

新しい機会を逃さないで!

確認メールの送信先

メールを確認し、リンクをクリックして求人情報の受信を開始します。

さらに試す:

最新の求人情報を受け取ることができます。

cancer 求人 全国 南砺

次も興味があるかもしれません:

RAS

Oncology

Novel

Advertisement

確認メールの送信先

メールを確認し、リンクをクリックして求人情報の受信を開始します。

すべてのフィルタ 申請する
ソート
雇用主/採用担当者